flutamide has been researched along with Adenocarcinoma, Follicular in 1 studies
Flutamide: An antiandrogen with about the same potency as cyproterone in rodent and canine species.
Adenocarcinoma, Follicular: An adenocarcinoma of the thyroid gland, in which the cells are arranged in the form of follicles. (From Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the application value of The American College of Radiology (ACR) Thyroid Imaging Reporting and Data System (TI-RADS) category combined with other ultrasound features of nodules in distinguishing follicular thyroid carcinoma (FTC) from thyroid follicular adenoma (FTA)." | 1.72 | ACR TI-RADS classification combined with number of nodules, halo features optimizes diagnosis and prediction of follicular thyroid cancer. ( Hao, SY; Luo, BM; Qiu, Y; Ruan, JL; Tan, L; Wu, SJ; Yang, HY, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, SJ | 1 |
| Tan, L | 1 |
| Ruan, JL | 1 |
| Qiu, Y | 1 |
| Hao, SY | 1 |
| Yang, HY | 1 |
| Luo, BM | 1 |
1 other study available for flutamide and Adenocarcinoma, Follicular
| Article | Year |
|---|---|
ACR TI-RADS classification combined with number of nodules, halo features optimizes diagnosis and prediction of follicular thyroid cancer.
Topics: Adenocarcinoma, Follicular; Flutamide; Humans; Retrospective Studies; Thyroid Neoplasms; Thyroid Nod | 2022 |